The patient was paid pretty well, but even with all the bad side effects he had, he kept on promoting the drug until it reached the point to where he had to come clean it appears. He had only taken the drug for 4 days when the commercial endorsement was filmed. After a year, he continued to talk favorably about the drug, even though he had quit using it.
The drug is for treatment of bi-polar illness, which falls into the area of mental illness, so this one appears to be a somewhat difficult area to prove one way or the next and I would guess only trial or medical records by physicians would lend additional information here. BD
An old journalism professor once told me, “If your mother says she loves you, check it out.” Same goes, unfortunately, for patients praising their treatments. Some are being paid to do so.
A front-page story in The Wall Street Journal pulls back the curtain on paid endorsers with a profile of Andy Behrman, who suffers from bipolar disorder. Bristol-Myers Squibb gave him $400,000 for testimonials about Abilify, an antipsychotic.